Vaccination with 73 kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models

Vaccine

Volumn 26, Issue 47, 2008, Pages 5997-6005

  Vedi, Satish ^a   Dangi, Anil ^a   Hajela, Krishnan ^b   Misra Bhattacharya, Shailja ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b DEVI AHILYA UNIVERSITY   (India)

Author keywords

Brugia malayi; Filarial vaccination; Immune response; Recombinant myosin

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; MYOSIN HEAVY CHAIN; NITRIC OXIDE; RECOMBINANT HEAVY CHAIN MYOSIN; UNCLASSIFIED DRUG; DNA VACCINE; HELMINTH ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BRUGIA MALAYI; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNITY; IMMUNOPROPHYLAXIS; IMMUNOREACTIVITY; LYMPHOCYTE; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MASTOMYS; MICROFILARIA; MOLECULAR WEIGHT; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; RODENT; SPLEEN CELL; VACCINATION; ANIMAL; DISEASE MODEL; GENETICS; GERBIL; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPHATIC FILARIASIS; LYMPHOCYTE ACTIVATION; MURINAE; PARASITOLOGY;

ANIMALS; ANTIBODIES, HELMINTH; BRUGIA MALAYI; DISEASE MODELS, ANIMAL; ELEPHANTIASIS, FILARIAL; GERBILLINAE; HUMANS; LYMPHOCYTE ACTIVATION; MICROFILARIA; MURINAE; MYOSIN HEAVY CHAINS; RECOMBINANT PROTEINS; VACCINATION; VACCINES, DNA;

EID: 55249111256     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.08.073     Document Type: Article

References (63)

1. Melrose W.D., and Rahmah N. Use of Brugia rapid dipstick and ICT test to map distribution of lymphatic filariasis in the Democratic Republic of Timor-Leste. Southeast Asian J Trop Med Public Health 37 1 (2006) 22-25
2. Michael E., Bundy D.A.P., and Grenfell B.T. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 112 (1996) 409-428
3. Ramaiah K.D., Das P.K., Micheal E., and Guyatt H.L. The economic burden of lymphatic filariasis in India. Parasitol Today 16 (2000) 251-253
4. Michael E., and Bundy D.A.P. Global mapping of lymphatic filariasis. Parasitol Today 13 (1997) 472-476
5. Ottesen E.A., Duke B.O., Karam M., and Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 75 (1997) 491-493
6. World Health Organization. The world health report 2002: reducing risks and promoting healthy life (2002), WHO, Geneva
7. Peixoto A., Alves L.C., Brayner F.A., and Florêncio M.S. Diethylcarbamazine induces loss of microfilarial sheath of Wuchereria bancrofti. Mícron 38 8 (2003) 380-385
8. Florêncio M.S., and Peixoto C.A. The effects of diethylcarbamazine on the ultrastructure of microfilariae of Wuchereria bancrofti. Parasitology 126 6 (2003) 551-554
9. Molyneux D., and Zagaria N. Lymphatic filariasis elimination: progress in global programme development. Ann Trop Med Parasitol 96 (2002) S15-S40
10. Critchley J., Addiss D., Ejere H., Gamble C., Garner P., and Gelband H. Albendazole for the control and elimination of lymphatic filariasis: systematic review. Trop Med Int Health 10 9 (2005) 818-825
11. Schwab A.E., Churcher T.S., Schwab A.J., Basanez M.G., and Prichard R.K. An analysis of the population genetics of potential multi-drug resistance in Wuchereria bancrofti due to combination chemotherapy. Parasitology (2007) 1-16
12. Wolstenholme A.J., Fairweather I., Prichard R., von Samson-Himmelstjerna G., and Sangster N.C. Drug resistance in veterinary helminths. Trends Parasitol 20 (2004) 469-476
13. Bourguinat C., Pion S.D.S., Kamgno J., Gardon J., Duke B.O.L., Boussinesq M., et al. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS Negl Trop Dis 1 1 (2007) e72
14. Lustigman S., and McCarter J.P. Ivermectin resistance in Onchocerca volvulus: toward a genetic basis. PLoS Negl Trop Dis 1 1 (2007) e76
15. Duan J.H., Li Z.X., Zhang K.R., Luo H.Q., Zeng X.W., and Zhang D.R. Observation on the persistence period and transmission of residual microfilaremia with medium and higher density. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 18 3 (2000) 167-169
16. Duan J.H., Luo H.Q., Zhang K.R., Zhang M., Zeng X.W., Li Z.X., et al. Density fluctuation of microfilariae and the role of residual infection source in filariasis transmission after its interruption. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 25 6 (2007) 457-461
17. Addiss D.G., and Brady M.A. Morbidity management in the global programme management to eliminate lymphatic filariasis: a review of the scientific literature. Filaria J 6 (2007) 2
18. Lightowlers M.W., Colebrook A.L., Gauci C.G., Gauci S.M., Kyngdon C.T., Monkhouse J.L., et al. Vaccination against cestode parasites: anti helminth vaccines that work and why. Vet Parasitol 115 (2003) 83-123
19. Hotez P.J., Zhan B., Bethony J.M., Loukas A., Williamson A., Goud G.N., et al. Progress in the development of a recombinant vaccine for human hookworm disease: the human hookworm vaccine initiative. Int J Parasitol 33 (2003) 1245-1258
20. Abraham D., Lucius R., and Trees A.J. Immunity to Onchocerca spp. in animal hosts. Trends Parasitol 18 (2002) 164-170
21. Babayan S.A., Attout T., Harris A., Taylor M.D., Le Goff L., Vuong P.N., et al. Vaccination against filarial nematodes with irradiated larvae provides long-term protection against the third larval stage but not against subsequent life cycle stages. Int J Parasitol 36 (2006) 903-914
22. Li Ben-W, Zhang S., Curtis K.C., and Weil G.J. Immune responses to Brugia malayi paramyosin in rodents after DNA vaccination. Vaccine 18 (2000) 76-81
23. Harrison R.A., Wu Y., Egerton G., and Bianco A.E. DNA immunisation with Onchocerca volvulus chitinase induces partial protection against challenge infection with L3 larvae in mice. Vaccine 18 (2000) 647-655
24. Pokharel D.R., Rai R., Nanda kumar Kodumudi K., Reddy M.V., and Rathaur S. Vaccination with Setaria cervi 175 kDa collagenase induces high level of protection against Brugia malayi infection in jirds. Vaccine 24 (2006) 6208-6215
25. Misra-Bhattacharya S., and Gupta R. Vaccine prospects in human filariasis. J Immunol Immunopathol 4 1/2 (2002) 117-121
26. Verma S., Bansal I., Vedi S., Saxena J.K., Katoch V.M., and Misra-Bhattacharya S. Molecular cloning, purification and characterization of myosin of human lymphatic filarial parasite Brugia malayi. Parasitol Res 102 3 (2008) 481-490
27. Singh U., Misra S., Muthy P.K., Katiyar J.C., Agrawal A., and Sircar A.R. Immunoreactive molecules of Brugia malayi and their diagnostic potential. Sero Immuno Infect Dis 8 (1997) 207-212
28. Misra S., Singh D.P., Murthy P.K., and Chatterjee R.K. Mode of action of antifilarials: modulation of immune adherence of cells to microfilariae in vitro. Trop Med Int Health 32 (1990) 33-43
29. Misra S., Mukherjee M., Dixshit M., and Chaterjee R.K. Cellular response of Mastomys and gerbil in experimental filariasis. Trop Med Int Health 3 2 (1998) 124-129
30. Zurgil N., Shafran Y., Afrimzon E., Fixler D., Shainberg A., and Deutsch M. Concomitant real-time monitoring of intracellular reactive oxygen species and mitochondrial membrane potential in individual living promonocytic cells. J Immunol Methods 316 (2006) 27-41
31. Ottesen E.A. Infection and disease in lymphatic filariasis: an immunological perspective. Parasitology 104 (1992) S71-S79
32. Freedman D.O., Nutman T.B., and Ottesen E.A. Protective immunity in bancroftian filariasis selective recognition of a 43-kDa larval stage antigen by infection-free individuals in an endemic area. J Clin Invest 83 (1989) 14-22
33. Lustigman S., James E.R., Tawe W., and Abraham D. Towards a recombinant antigen vaccine against Onchocerca volvulus. Trends Parasitol 18 (2002) 135-141
34. Macdonald A.J., Tawe W., Leon O., Cao L., Liu J., Oksov Y., et al. Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity. Parasite Immunol 26 (2004) 53-62
35. Chenthamarakshan V., Reddy M.V., and Harinath B.C. Immunoprophylactic potential of a 120kDa Brugia malayi adult antigen fraction BmA-2, in lymphatic filariasis. Parasite Immunol 17 6 (1995) 277-285
36. Gregory W.F., Atmadja A.K., Allen J.E., and Maizels R.M. The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis. Infect Immun 68 7 (2000) 4174-4179
37. Ramachandran S., Kumar M.P., Rami R.M., Chinnaiah H.B., Nutman T., Kaliraj P., et al. The larval specific lymphatic filarial ALT-2: induction of protection using protein or DNA vaccination. Microbiol Immunol 48 12 (2004) 945-955
38. Thirugnanam S., Pandiaraja P., Ramaswamy K., Murugan V., Gnanasekar M., Nandakumar K., et al. Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model. Exp Parasitol 116 4 (2007) 483-491
39. El Bouhdidi A., Truyens C., Rivera M.T., Bazin H., and Carlier Y. Trypanosoma cruzi infection in mice induces a polyisotypic hypergammaglobulinaemia and parasite-specific response involving high IgG2a concentrations and highly avid IgG1 antibodies. Parasite Immunol 16 (1994) 69-76
40. Kanai N., Min W.P., Ichim T.E., and Wang H. Th1/Th2 Xenogenic antibody responses are associated with recipient dendritic cells. Microsurgery 27 (2007) 234-239
41. Pulendran B., Smith J.L., Caspary G., Brasel K., Pettit D., Maraskovsky E., et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA 96 (1999) 1036-1041
42. Shyur S.D., Raff H.V., Bohnsack J.F., Kelsey D.K., and Hill H.R. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B. streptococci. J Immunol 148 (1992) 1879-1884
43. Elson L.H., Calvopina M., Paredes W., Araujo E., Bradley J.E., Guderian R.H., et al. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus. J Infect Dis 171 (1995) 652
44. Dimock K.A., Eberhard M.L., and Lammie P.J. Th1-like antifilarial immune responses predominate in antigen-negative persons. Infect Immun 64 (1996) 2962
45. Hussain R., Grogl M., and Ottesen E.A. IgG antibody subclasses in human filariasis: differential subclass recognition of parasite antigens correlates with different clinical manifestations of infection. J Immunol 139 8 (1987) 2794-2798
46. Bal M., and Das M.K. Antibody response to a filarial antigen fraction in individuals exposed to Wuchereria bancrofti infection in India. Acta Trop 72 (1999) 259-274
47. Rajan T.V., Porte P., Yates J.A., Keefer L., and Shultz L.D. Role of nitric oxide in host defense against an extracellular, metazoan parasite, Brugia malayi. Infect Immun 15 (1996) 619-623
48. Taylor M., Cross H.F., Mohammed A.A., Trees A.J., and Bianco A.E. Susceptibility of Brugia malayi and Onchocerca lienalis microfilariae to nitric oxide and hydrogen peroxide in cell free culture and from IFN-γ activated macrophages. Parasitology 112 (1996) 315-322
49. Thomas G.R., McCrossan M., and Selkirk M.E. Cytostatic and cytotoxic effects of activated macrophages and nitric oxide donors on Brugia malayi. Infect Immun 65 (1997) 2732-2739
50. Gupta R., Bajpai P., Tripathi L.M., Srivastava V.M.L., Jain S.K., and Misra-Bhattacharya S. Macrophages in the development of protective immunity against experimental Brugia malayi infection. Parasitology 129 (2004) 311-323
51. Bandi C., Anderson T.J.C., Genchi C., and Blaxter M.L. Phylogeny of Wolbachia in filarial nematodes. Proc Nat Bio Sci USA 265 (1998) 2407-2413
52. Hoerauf A., Nissen-Pähle K., and Schmetz C. Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility. J Clin Invest 103 (1999) 11-18
53. Taylor A.E.R. The Development of Dirofilaria immitis in mosquito Aedes aegypti. J Heminthol 34 (1960) 27
54. Laurence B.R., and Simpson M.G. The microfilariae of Brugia: a first stage of nematode. J Heminthol 45 (1971) 23
55. Collins W.K. Ultastructure morphology of the esophageal region of the infective larva of Brugia phangi (Nematoda: Filarioidea). J Parasitol 57 (1971) 449
56. Howells R.E. In: Vanden Bossche H. (Ed). Filaria: dynamics of the surface in the host invader interplay (1980), North Holland, Elsevier, Amsterdem 69
57. Peralta M.E., Schmitz A.K., and Rajan T.V. Failure of highly immunogenic filarial proteins to provide host-protective immunity. Exp Parasitol 91 (1999) 334-340
58. Soisson L.A., and Strand M. Schistosoma mansoni: induction of protective immunity in rats using a recombinant fragment of a parasite surface antigen. Exp Parasitol 77 (1993) 492-494
59. Bergquist N.R. Controlling schistosomiasis by vaccination: a realistic option?. Parasitol Today 11 (1995) 191-194
60. Zhang Y., Taylor M.G., and Bickle Q.D. Schistosoma japonicum myosin: cloning, expression and vaccination studies with the homologue of the S. mansoni myosin fragment IrV-5. Parasite Immunol 20 (1998) 583-594
61. Zhang Y., Taylor M.G., Gregoriadis G., McCrossan M.V., and Bickle Q.D. Immunogenicity of plasmid DNA encoding the 62 kDa fragment of Schistosoma japonicum myosin. Vaccine 18 (2000) 2102-2109
62. Misra S., Tyagi K., and Chatterjee R.K. Experimental transmission of nocturnally periodic Wuchereria bancrofti to Indian leaf monkey (Presbytis entellus). Exp Parasitol 86 2 (1997) 155-157
63. Srivastava K., Vedi S., Srivastava S., and Misra-Bhattacharya S. Wuchereria bancrofti: effect of single and multiple larval inoculations on infection dynamics and development of clinical manifestations in non-human primate Presbytis entellus. Exp Parasitol 115 (2007) 305-309